Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinichi Toyooka

Showing results (491-500 of 537) with videos related to

Pageof 54
Sort By:
Oncology Letters|November 16, 2020
Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reactionKazuya Nishii, Kadoaki Ohashi, Tomoki Tamura, et al.
The Lancet. Oncology|December 22, 2009
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trialTetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 10, 2020
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosisKota Araki, Rie Kinoshita, Nahoko Tomonobu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 3, 2019
Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation BurdenGo Makimoto, Kadoaki Ohashi, Shuta Tomida, et al.
International Journal of Cancer|January 1, 2009
MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitorsTakafumi Kubo, Hiromasa Yamamoto, William W Lockwood, et al.
Medicine|August 10, 2020
A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)Kenta Takahashi, Eri Ishibashi, Toshio Kubo, et al.
Frontiers in Oncology|March 13, 2023
LOXL1 and LOXL4 are novel target genes of the Zn<sup>2+</sup>-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cellsDaisuke Hirabayashi, Ken-Ichi Yamamoto, Akihiro Maruyama, et al.
Scientific Reports|November 30, 2022
Early-stage antibody kinetics after the third dose of BNT162b2 mRNA COVID-19 vaccination measured by a point-of-care fingertip whole blood testingHideharu Hagiya, Yasuhiro Nakano, Masanori Furukawa, et al.
Journal of Thoracic Disease|March 20, 2024
Effects of case volume on short- and long-term outcomes following cadaveric lung transplantation in JapanMasayuki Chida, Takashi Inoue, Takahiro Nakajima, et al.
Breast Cancer (Tokyo, Japan)|July 9, 2024
The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10Shogo Nakamoto, Takayuki Iwamoto, Naruto Taira, et al.
Pageof 54

Showing results (491-500 of 537) with videos related to

Sort By:
Pageof 54
Oncology Letters|November 16, 2020
Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reactionKazuya Nishii, Kadoaki Ohashi, Tomoki Tamura, et al.
The Lancet. Oncology|December 22, 2009
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trialTetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 10, 2020
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosisKota Araki, Rie Kinoshita, Nahoko Tomonobu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 3, 2019
Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation BurdenGo Makimoto, Kadoaki Ohashi, Shuta Tomida, et al.
International Journal of Cancer|January 1, 2009
MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitorsTakafumi Kubo, Hiromasa Yamamoto, William W Lockwood, et al.
Medicine|August 10, 2020
A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)Kenta Takahashi, Eri Ishibashi, Toshio Kubo, et al.
Frontiers in Oncology|March 13, 2023
LOXL1 and LOXL4 are novel target genes of the Zn<sup>2+</sup>-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cellsDaisuke Hirabayashi, Ken-Ichi Yamamoto, Akihiro Maruyama, et al.
Scientific Reports|November 30, 2022
Early-stage antibody kinetics after the third dose of BNT162b2 mRNA COVID-19 vaccination measured by a point-of-care fingertip whole blood testingHideharu Hagiya, Yasuhiro Nakano, Masanori Furukawa, et al.
Journal of Thoracic Disease|March 20, 2024
Effects of case volume on short- and long-term outcomes following cadaveric lung transplantation in JapanMasayuki Chida, Takashi Inoue, Takahiro Nakajima, et al.
Breast Cancer (Tokyo, Japan)|July 9, 2024
The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10Shogo Nakamoto, Takayuki Iwamoto, Naruto Taira, et al.
Pageof 54